LONDON – Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease.
Diabetes regimens,…
Source: www.japantimes.co.jp – Read more
Infosys: US court grants final approval to the settlement between McCamish and plaintiffs in 2023 cyber incident | DETAILS – ET Now
Infosys: US court grants final approval to the settlement between McCamish and plaintiffs in 2023 cyber incident | DETAILS ET Now

